Systematic review of the efficacy of rivastigmine for patients with Alzheimer's disease

International Journal of Geriatric Psychopharmacology

Volumn 1, Issue SUPPL. 1, 1998, Pages

  Schneider, L S ^a   Anand, R ^a   Farlow, M R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Acetylcholinesterase inhibitors; ADAS Cog; ADENA; Alzheimer's disease; CIBIC Plus; Progressive Deterioration Scale; Rivastigmine

Indexed keywords

CHOLINESTERASE INHIBITOR; CIMETIDINE; DONEPEZIL; IBUPROFEN; PLACEBO; RIVASTIGMINE; TACRINE; THEOPHYLLINE; VELNACRINE;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMENTIA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; FUNCTIONAL ASSESSMENT; GERONTOPSYCHIATRY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; TREATMENT OUTCOME;

EID: 0031647045     PISSN: 13648233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)